Latest Blogs

Apr 02, 2020
Dr. Martina Murphy, Dr. Devika Das, and Dr. Elizabeth Henry consider how the COVID-19 pandemic is affecting hematology/oncology training, and offer tips for staying connected to trainees.
Apr 01, 2020
Dr. Mona Hassan arrived in the United States excited for professional development and activism opportunities. Within a week, COVID-19 completely derailed her plans.
Apr 01, 2020
The TMPRSS2 protein has a role in both COVID-19 and in prostate cancer, suggesting intriguing avenues of inquiry for researchers engaged in the fight against COVID-19.
Mar 31, 2020
Dr. Inas Abuali attempts to make sense of the shifting tides and what they mean for her patients, colleagues, and loved ones (while maintaining safe social distance from her co-fellows).
Subscribe to this column

Clifford A. Hudis, MD, FACP, FASCO

Clifford A. Hudis, MD, FACP, FASCO, is the CEO of ASCO. Prior to this role, he served as chief of the Breast Medicine Service and an attending physician at Memorial Sloan Kettering Cancer Center and as a professor in the Department of Medicine at Weill Cornell Medical College. He is a past president of ASCO. His research interests include all areas of care related to breast cancer, with a focus on the development of novel systemic therapies and prevention interventions related to obesity and inflammation. Follow Dr. Hudis on Twitter @CliffordHudis.

Jan 28, 2019
Editor’s note: Dr. Hudis hosts the ASCO in Action Podcast, which focuses on policy and practice issues affecting providers and patients. An excerpt of a recent episode is shared below; it has been edited for length and clarity.
Jan 14, 2019
Social injustice is perpetuated when patients can't afford to participate in essential clinical research.
Oct 03, 2018
The chair-elect of the ASCO Health Equity Committee and I discuss concerns with proposed Medicaid work requirements and their impact on patients with cancer and their physicians.
Sep 11, 2018
We remain very concerned that the CMS proposal could harm Medicare beneficiaries who have cancer by triggering major cuts to physician reimbursement, especially for Part B drugs and for drugs that have been newly introduced to the market.
Aug 28, 2018
At the latest ASCO Board of Directors Meeting, we discussed countering biases, improving rural access to quality cancer care, and effectively adding more value to your ASCO membership. 
Aug 24, 2018
ASCO's "I Live to Conquer Cancer" campaign is putting a human face on the results of cancer research and the researchers who make this progress.

Pages